MAXIM PHARMACEUTICALS ANNOUNCES TWO U.S. PATENTS ISSUED FOR CASPASE INHIBITORS
27-Mar-2001
Most read news
Topics
patents
inhibitors
diseases
apoptosis
Maxim Pharmaceuticals
oral mucositis
melanoma
infectious diseases
herpes
enzymes
degenerative disorder
clinical trials
cardiovascular diseases
acute myeloid leukemia
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.